Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peripheral Blood cfDNA Methylation, Fragmentation, and Proteomics for Multiple Cancers Early Detection: a Multicenter, Prospective, Observational, Case-control Study

NCT05874648 is registered in ClinicalTrials.gov with Sixth Affiliated Hospital, Sun Yat-sen University as lead sponsor.

NCT NCT05874648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05874648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peripheral Blood cfDNA Methylation, Fragmentation, and Proteomics for Multiple Cancers Early Detection: a Multicenter, Prospective, Observational, Case-control Study
Lead sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Observational
Overall status
Unknown status
Start date
July 7, 2023
Completion date
October 31, 2024
Enrollment
3,830 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasms